ACT Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,499
Closed -$314K 30
2022
Q2
$314K Sell
3,499
-674
-16% -$68.3K 0.23% 23
2022
Q1
$463K Buy
4,173
+10
+0.2% +$1.06K 0.3% 20
2021
Q4
$431K Buy
4,163
+9
+0.2% +$1.04K 0.32% 25
2021
Q3
$521K Sell
4,154
-150
-3% -$19.4K 0.4% 22
2021
Q2
$546K Hold
4,304
0.41% 23
2021
Q1
$565K Sell
4,304
-25
-0.6% -$2.93K 0.45% 22
2020
Q4
$507K Buy
+4,329
New +$477K 0.46% 21

Other funds holding MDT

ACT Advisors's MDT Position: Q3 2022 in Review

ACT Advisors sold out of Medtronic (MDT) in Q3 2022, closing a stake of 3,499 shares — an estimated $314K sold.

ACT Advisors first reported a position in MDT in Q4 2020 and held it in 7 quarters. The position peaked at $565K in Q1 2021. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • ACT Advisors reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • ACT Advisors sold 3,499 Medtronic shares in Q3 2022, an estimated $314K.
  • ACT Advisors first reported a position in Medtronic in Q4 2020 and held it in 7 quarters.
  • ACT Advisors's Medtronic position peaked at $565K in Q1 2021.
  • 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on ACT Advisors's 13F filing for Q3 2022, filed 6 Oct 2022.